购物车
0
有库存
HIT212713884
 sdf 文件
结构编辑
类似物检索
HIT212713884
  • HIT ID:HIT212713884
  • Cas No:957791-38-7
  • 常用名:VAL-201
  • 别名:VAL201, VAL 201
  • IUPAC:(2S)-1-[(2S)-1-[(2S)-1-acetylpyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]-N-[(2S)-1-[(2S)-2-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(1S)-5-amino-1-carbamoylpentyl]carbamoyl}-2-methylbutyl]carbamoyl}-4-carbamimidamidobutyl]carbamoyl}ethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide
    IUPAC:(2S)-1-[(2S)-1-[(2S)-1-acetylpyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]-N-[(2S)-1-[(2S)-2-{[(1S)-1-{[(1S)-1-{[(1S)-1-{[(1S,2S)-1-{[(1S)-5-amino-1-carbamoylpentyl]carbamoyl}-2-methylbutyl]carbamoyl}-4-carbamimidamidobutyl]carbamoyl}ethyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}pyrrolidin-1-yl]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]pyrrolidine-2-carboxamide
  • InChI key:OCAUTAUXGFCFEB-MGFBIKGDSA-N
  • 分子式:C55H87N19O11
  • 分子量:1190.423
  • 氢键供体数 (HBD):13
  • 氢键受体数 (HBA):17
  • LogP:-6.657381
  • SMILES:CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(C)=O)C(=O)N[C@@H](CCCCN)C(N)=O
    SMILES:CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(C)=O)C(=O)N[C@@H](CCCCN)C(N)=O
  • VAL-201, an androgen receptor antagonist, is used potentially for the treatment of prostate cancer.
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    纯度
    -
    ¥ 10,600.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymol随时为您提供帮助。
电话:400-820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~